Status:
RECRUITING
ENDO-BRAIN: Effects of Endocrine Adjuvant Therapy with Aromatase Inhibitors on the Cognitive Function of Breast Cancer Patients
Lead Sponsor:
Ospedale Policlinico San Martino
Collaborating Sponsors:
University of Genova
Conditions:
Cognitive Side Effects of Cancer Therapy
Hypoestrogenism
Eligibility:
FEMALE
18+ years
Brief Summary
The principal aim of this prospective observational study is to investigate the cognitive function of breast cancer patients that use AI, comparing it with age-matched healthy controls, utilizing cogn...
Eligibility Criteria
Inclusion
- Breast cancer patients undergoing endocrine adjuvant therapy with AI, with or without GnRH agonists, depending on menopause status at diagnosis (cases only)
- At least 18 years old
- Good comprehension of oral and written Italian language
Exclusion
- incomplete ovarian suppression (cases)
- previous neoplastic diseases other than the presently treated breast cancer for cases
- known neurological or psychiatric disorders
- use of hormonal contraception or hormonal replacement therapy (controls)
Key Trial Info
Start Date :
June 13 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06606535
Start Date
June 13 2024
End Date
June 1 2025
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS Ospedale Policlinico San Martino
Genova, GE, Italy, 16132